Ultromics

To add a bio or update company history, please click update information.

News from Ultromics

Ultromics raises £40m Series C led by L&G, Allegis Capital and Lightrock to expand AI heart failure diagnostics in the US

31 Jul 2025

Ultromics raises £40m Series C led by L&G, Allegis Capital and Lightrock to expand AI heart failure diagnostics in the US

Ultromics develops AI software that analyses echocardiograms to help clinicians detect hard-to-diagnose heart failure conditions earlier, without requiring new hardware or changes to existing clinical workflows.

Ultromics

Health
Oxford, United Kingdom
£40m
ultromics.com
Update Information

More venture news

BeCertain
16 Jul 2026
BeCertain raises a £1.7m pre-seed round led by Sure Valley Ventures for AI software that helps dentists interpret X-rays
Pre-seedHealth
Leo Cancer Care
9 Jul 2026
Leo Cancer Care unlock £50m Series D led by Yu Galaxy for its upright imaging and radiotherapy platform
Series DHealth
Respiro Diagnostics
8 Jul 2026
Respiro Diagnostics raises a £1m pre-seed round led by Zinc Venture Capital and SFC Capital to develop breath-based liquid biopsy for lung cancer
Pre-seedHealth

Ultromics

News from Ultromics

Ultromics raises £40m Series C led by L&G, Allegis Capital and Lightrock to expand AI heart failure diagnostics in the US

More venture news

BeCertain raises a £1.7m pre-seed round led by Sure Valley Ventures for AI software that helps dentists interpret X-rays

Leo Cancer Care unlock £50m Series D led by Yu Galaxy for its upright imaging and radiotherapy platform

Respiro Diagnostics raises a £1m pre-seed round led by Zinc Venture Capital and SFC Capital to develop breath-based liquid biopsy for lung cancer